Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kataoka K et al. – Within patients who survived without relapse >1 year after HSCT, the HCT–CI did not predict OS or NRM. These findings can be useful to determine the role of pretransplant comorbidity in allogeneic HSCT.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address